Evidence map›Paper›PMID 27139822›Full record

ArticleThe Journal of allergy and clinical immunology2016

Humanized mouse model of mast cell-mediated passive cutaneous anaphylaxis and passive systemic anaphylaxis.

Paul J Bryce, Rustom Falahati, Laurie L Kenney, John Leung, Christopher Bebbington, Nenad Tomasevic, Rebecca A Krier, Chia-Lin Hsu, Leonard D Shultz, Dale L Greiner and 1 more

Abstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 100 citations in OpenAlex.

  1. Article
  2. The long noncoding RNAFrontiers in immunology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Preclinical models in the study of lymph node metastasis.Journal of Zhejiang University. Science. B · 2025
    Review
  7. Importance of mast cell histamine secretion in IgG-mediated systemic anaphylaxis.The Journal of allergy and clinical immunology · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. A Monocytic Barrier to the Humanization of Immunodeficient Mice.Current stem cell research & therapy · 2024
    Review
  17. Review
  18. Review
  19. Review
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Paul J BryceDepartment of Medicine, Division of Allergy-Immunology, Northwestern University Feinberg School of Medicine, Chicago, Ill.
Rustom FalahatiAllakos Inc, San Carlos, Ill.
Laurie L KenneyDiabetes Center of Excellence, Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, Mass.
John LeungAllakos Inc, San Carlos, Ill.
Christopher BebbingtonAllakos Inc, San Carlos, Ill.
Nenad TomasevicAllakos Inc, San Carlos, Ill.
Rebecca A KrierDepartment of Medicine, Division of Allergy-Immunology, Northwestern University Feinberg School of Medicine, Chicago, Ill.
Chia-Lin HsuDepartment of Medicine, Division of Allergy-Immunology, Northwestern University Feinberg School of Medicine, Chicago, Ill.
Leonard D ShultzJackson Laboratory, Bar Harbor, Me.
Dale L GreinerDiabetes Center of Excellence, Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, Mass.
Michael A BrehmDiabetes Center of Excellence, Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, Mass. Electronic address: michael.brehm@umassmed.edu.
Allakos (United States) · USNorthwestern University · USUniversity of Massachusetts Chan Medical School · USJackson Laboratory · US

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI William Carl Skarnes · 1985 to 2026
$61.9M
Virology and Technology CoreP01AI046629 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GREINER, DALE LESLIE · 1999 to 2014
$19.1M
Regulation of T cell migration by histamineR01AI076456 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HULSE, KATHRYN ELIZABETH · 2008 to 2017
$3.9M
Development and Validation of Novel NSG Mouse Models for Human Stem Cell TherapyR24OD018259 · OD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BREHM, MICHAEL ALLEN, GREINER, DALE LESLIE · 2014 to 2017
$3.0M
Regulation of food allergy and anaphylaxis by IL 33R01AI105839 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BOCHNER, BRUCE S · 2014 to 2018
$1.8M
NCI NIH HHS P30 CA034196NIAID NIH HHS P01 AI046629NIAID NIH HHS R01 AI076456NIAID NIH HHS R01 AI105839NIH HHS R24 OD018259
6 · The paper itself

Abstract

backgroundMast cells are a critical component of allergic responses in humans, and animal models that allow the in vivo investigation of their contribution to allergy and evaluation of new human-specific therapeutics are urgently needed.

objectiveTo develop a new humanized mouse model that supports human mast cell engraftment and human IgE-dependent allergic responses.

methodsThis model is based on the NOD-scid IL2rg(null)SCF/GM-CSF/IL3 (NSG-SGM3) strain of mice engrafted with human thymus, liver, and hematopoietic stem cells (termed Bone marrow, Liver, Thymus [BLT]).

resultsLarge numbers of human mast cells develop in NSG-SGM3 BLT mice and populate the immune system, peritoneal cavity, and peripheral tissues. The human mast cells in NSG-SGM3 BLT mice are phenotypically similar to primary human mast cells and express CD117, tryptase, and FcεRI. These mast cells undergo degranulation in an IgE-dependent and -independent manner, and can be readily cultured in vitro for additional studies. Intradermal priming of engrafted NSG-SGM3 mice with a chimeric IgE containing human constant regions resulted in the development of a robust passive cutaneous anaphylaxis response. Moreover, we describe the first report of a human mast cell antigen-dependent passive systemic anaphylaxis response in primed mice.

conclusionsNSG-SGM3 BLT mice provide a readily available source of human mast cells for investigation of mast cell biology and a preclinical model of passive cutaneous anaphylaxis and passive systemic anaphylaxis that can be used to investigate the pathogenesis of human allergic responses and to test new therapeutics before their advancement to the clinic.

Indexed as

Disease Models, AnimalAnaphylaxisAnimalsHematopoietic Stem Cell TransplantationHumansImmunoglobulin ELiver TransplantationMast CellsMicePassive Cutaneous AnaphylaxisThymus GlandImmunoglobulin Ehumanized miceMast cellNSGNSG-SGM3passive cutaneous anaphylaxispassive systemic anaphylaxisPCAPSA

Identifiers

PMID27139822
PMCPMC5014665
OpenAlexW2327451194

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.